1 follower
Ocugen Inc. (NASDAQ: OCGN) is a biopharmaceutical company focused on discovering, developing, and commercializing gene therapies to cure blindness diseases and developing a vaccine to fight COVID-19.
Shankar Musunuri
Kura Oncology
20 followers
Dyne Therapeutics
3 followers
Precigen
3 followers
Arcturus Therapeutics
2 followers
Biocytogen
2 followers
Gamida Cell
2 followers
Fortis Life Sciences
1 follower
Entrada Therapeutics
1 follower
Cabaletta Bio
1 follower
Janux Therapeutics
1 follower
Matica Biotechnology
1 follower
Explore companies